BGJ-33953-94505
4 vaccinations
6 coded responses
25 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 727 / AR
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Registered in v-safe
-
2021-03-26
Survey response — days 1–6 daily, dose 1MedDRA: Uterine haemorrhage — Feeling: GoodFree text: Unexpected uterine bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: Menopause, Uterine haemorrhage — Feeling: Good · Fatigue or tirednessFree text: Still having uterine spotting. (Dx menopausal June 2020 with no period/bleeding since Sept 2020)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-28
-
2021-03-29
Survey response — days 1–6 daily, dose 1MedDRA: Uterine haemorrhage — Feeling: GoodFree text: Uterine bleeding continuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Uterine haemorrhage — Feeling: GoodFree text: Still some uterine bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — day 7, dose 1MedDRA: Uterine haemorrhage — Feeling: GoodFree text: Uterine bleeding is diminishingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-07-14
-
2021-10-13
Survey response — 6 months, dose 2MedDRA: Impaired work ability, Office visit, Tinnitus, Vertigo — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Vertigo onset 09/01/21 and continuing bilateral tinnitus, unknown cause. Missed work, received medical care. Shingles vaccine received on 08/04/21 & 10/06/21. Side effects caused missed work 1 day following each dose.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-13
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-19
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-29
Dose 3 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-29
-
2022-07-06
Dose 4 — Pfizer-BioNTechCo-administered: Tetanus
- 2022-10-05
- 2023-01-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
| 4 | 2022-07-06 | Pfizer-BioNTech | Tetanus |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Unexpected uterine bleeding
Systemic reaction (other): Still having uterine spotting. (Dx menopausal June 2020 with no period/bleeding since Sept 2020)
Systemic reaction (other): Uterine bleeding continues
Systemic reaction (other): Still some uterine bleeding
Release 6 — day 7, dose 1
Systemic reaction (other): Uterine bleeding is diminishing
Release 10 — 6 months, dose 2
Symptoms: Vertigo onset 09/01/21 and continuing bilateral tinnitus, unknown cause. Missed work, received medical care. Shingles vaccine received on 08/04/21 & 10/06/21. Side effects caused missed work 1 day following each dose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Impaired work ability | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Menopause | ✓ | ✓ | ✓ |
| SRO | Uterine haemorrhage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release